CDRE Cadre Holdings, Inc. Insider Trading

CEO Warren Kanders sold 200,000 shares of CDRE for $6,333,000.00 across 2 trades; stock now -30.8% from 52-week high

CEO and Chairman Warren B. Kanders executed 2 separate sales totaling 200,000 shares (200.0K shares) for $6,333,000.00 on 2026-03-20 and 2026-03-23 at an average of $31.66, reducing his holdings by 2.0% from 10,117,039 to 9,917,039 shares post-transaction. The sales occurred during a period of pronounced stock weakness: the stock is currently -30.8% from its 52-week high of $46.07 and has declined -28.0% over the prior 30 days. His 16 prior cross-ticker sales carry a 56.25% well-timed rate with an average 90-day return of -1.9%, indicating modest but genuine historical accuracy in sell timing. At CDRE specifically, prior sales show mixed outcomes: his 5 prior trades at this ticker produced only 1 well-timed outcome at the 90-day mark, with recent November 2025 sales posting +3.8% to +8.2% 90-day returns (poorly timed). The latest sale occurs against a backdrop of near-term price deterioration but should be monitored against the stock's recent trajectory and valuation (P/E 25.50).

CFO Browers Blaine sold 20,435 shares of CDRE at $43.79 (now $41.74); holding declined 24.5% to 63,142 shares.

Browers Blaine, CFO of Cadre Holdings, sold 20,435 shares at $43.79 on 2025-12-12, reducing his post-transaction holdings to 63,142 shares—a 24.5% reduction from his pre-transaction 83,577 shares. The sale occurred near the 52-week high of $45.11 and significantly above the current price of $41.74. His prior sell at this ticker on 2024-11-12 was followed by a 90-day return of +6.6%, indicating the stock rose after that earlier sale rather than declining; across his full cross-ticker track record, his prior sells show an average 90-day return of +6.6%, with a well-timed rate of 0.00%, meaning none were followed by stock declines. The company's fundamentals show revenue of $155,869,000.00 and net income of $10,941,000.00 in the latest quarter, with 17.6% annual revenue growth, though the P/E ratio of 37.27 reflects a premium valuation.

Williams Brad sold 24,000 shares at $42.99, reducing CDRE stake by 30.5% to 54.7K shares.

Williams Brad, President of Cadre Holdings, sold 24,000 shares (24.0K shares) for $1,031,760.00 on 2025-12-10, reducing his post-transaction holdings to 54,719 shares (54.7K shares) from 78,719 shares—a 30.5% reduction in his position. The sale occurred at $42.99, near the stock's current price of $43.72 and just -3.1% from the 52-week high of $45.11, suggesting the transaction occurred in favorable price territory. At the same-ticker level, Williams' prior four measurable sells at CDRE showed mixed outcomes: three generated positive 90-day returns (+3.0%, +3.0%, +5.8%), while one from 2024-12-03 resulted in a -5.3% 90-day return; only 1 of 4 prior sells at this ticker were well-timed at the 90-day mark. The company trades at a P/E of 39.04 with recent fundamentals showing revenue of $155,869,000.00 and net income of $10,941,000.00, reflecting +17.6% annual revenue growth.

CEO Kanders sells 1.34M shares (11.7% of holdings) for $52.4M at $39.00 on 2025-11-17

KANDERS WARREN B executed 2 separate sales totaling 1,343,941 shares for $52,413,699.00, representing an 11.7% reduction in his stake at CDRE. The transactions occurred at $39.00 per share, which is $1.00 below the current price of $40.00 and 13.4% below the 52-week high of $45.11. His prior open-market trading at CDRE shows mixed timing: 3 of 5 prior sells yielded negative 90-day returns (well-timed), but 2 sales were followed by gains, indicating inconsistent execution relative to downturns. Cross-ticker, his 16 prior sells averaged a 56.25% well-timed rate with -2.1% average 90-day return, suggesting his sells have historically preceded modest declines. The company trades at a P/E of 35.71 with 17.6% annual revenue growth, reflecting a growth profile, and this large secondary sale by the CEO at near-52-week lows warrants examination of whether it signals a shift in insider conviction or reflects liquidity management unrelated to fundamental outlook.

CDRE president Williams sold 27.4K shares at $43.62; down 25.8% of holdings to 78.7K; P/E 37.58 valuation context

Williams Brad, CDRE president, executed a substantial sale of 27,370 shares at $43.62, reducing his holdings by 25.8% from 106,089 to 78,719 shares and realizing approximately $1.2M in proceeds. The company trades at a P/E of 37.58 with $155.9M quarterly revenue and +17.6% annual growth, presenting a growth-at-premium valuation. His cross-ticker sell track record shows an average 90-day return of +20.4% after sales and a 20% well-timed rate, while at CDRE specifically his prior 5 sales saw only 1 of 5 well-timed at 90 days (most recently a -5.3% 90-day outcome on 2024-12-03). The current price of $42.09 sits 6.7% below the 52-week high of $45.11, though stock has gained 42.9% over 90 days.

CDRE CEO Warren Kanders sells 25,000 shares at $32.78; stock now $32.97, off 18.0% from 52-week high.

Warren Kanders sold 25,000 shares on 2025-06-23 at $32.78, reducing his stake from 10.24M to 10.22M shares (a 0.2% reduction). The sale occurred near current price levels ($32.97) but with the stock 18.0% below its 52-week high of $40.22, suggesting the transaction came after a significant pullback from peak valuation. Kanders' cross-ticker track record shows 18 prior sells with a 90-day well-timed rate of 25.00%, indicating his historical sells have typically been poorly timed overall. At CDRE specifically, Kanders has executed 5 consecutive sales within three weeks (2025-05-30 through 2025-06-23), though measurable outcomes remain unavailable for all five transactions. The company's fundamentals remain solid—revenue of $130.1M, net income of $9.2M, and 17.6% annual revenue growth—but the P/E of 34.71 positions the stock above historical averages for valuation. The sustained selling pattern warrants tracking to determine whether it reflects operational constraints, portfolio rebalancing, or shifts in Kanders' conviction regarding the company's near-term trajectory.

CDRE CEO Kanders sells 100,000 shares across 2 transactions for $3,348,000.00, reducing stake by 1.0%

KANDERS WARREN B, CEO and Chairman of Cadre Holdings, executed 2 separate sales totaling 100,000 shares for $3,348,000.00 at a blended average price of $33.48. The stock currently trades at $32.79, down 18.5% from its 52-week high of $40.22. This sale reduces Kanders' post-transaction holdings to 10,241,192 shares from 10,341,192 shares, a 1.0% reduction. Notably, Kanders has engaged in 5 prior sales at CDRE within the past month (2025-05-28 through 2025-06-23), suggesting a pattern of regular liquidation. His broader cross-ticker track record shows 18 prior sells with a poorly-timed 90-day outcome rate (average 90d return of +3.6%, meaning the stock typically rose after his sales), though same-ticker performance at CDRE is not yet measurable. The combination of sustained sales activity and selling into a stock that remains above the current price—despite trading well below its recent high—warrants observation.

CEO Kanders sold 125,000 CDRE shares for $4.2M in two transactions, reducing stake by 1.2% amid recent high activity.

CEO and Chairman Warren B. Kanders executed 2 separate sales totaling 125,000 shares for $4,200,750.00 at an average price of $33.61, reducing his post-transaction holdings to 10.34M shares from 10.47M shares. This sale follows five additional sales at CDRE within a 10-day window (May 22–June 3), suggesting sustained liquidity action during a period when the stock has appreciated 14.7% over 30 days but remains 15.6% below its 52-week high. His cross-ticker track record shows 20 prior sales with a 100.00% well-timed rate at the 90-day mark (average 90d return -4.6%), though outcomes are not yet measurable for his recent CDRE sales. The frequency and scale of these recent open-market dispositions warrant investor attention, particularly given his substantial remaining stake of 10.34M shares and the company's strong fundamentals (revenue $130.1M, net income $9.2M, P/E 35.75).

CDRE CEO Kanders sold 50,000 shares at $32.75 on 2025-05-30; stock up 13.0% in 30 days but -16.5% from 52-week high.

Warren B. Kanders, CEO and Chairman of Cadre Holdings, sold 50,000 shares at $32.75 on 2025-05-30, reducing his holdings from 10.52M to 10.47M shares. The sale represents a minimal reduction of -0.5% of pre-transaction holdings. Context is mixed: the stock has gained 13.0% over the past 30 days and currently trades at $33.59, but remains 16.5% below its 52-week high of $40.22. Kanders' cross-ticker track record shows strong timing discipline (100.00% well-timed rate on 20 prior sells), though this is the fifth consecutive sale at CDRE within an 12-day window (May 22–June 3), and the outcomes on those earlier May trades are not yet measurable. The company's fundamentals appear solid: annual revenue growth of 17.6%, net income of $9.2M on $130.1M in latest quarterly revenue, though the P/E of 35.36 reflects a premium valuation.

CEO Warren Kanders sold 100,000 CDRE shares for $3,290,500.00 over two days at $33.11–$32.70; retains 10.52M shares.

Warren Kanders, CEO and Chairman, executed 2 separate sales totaling 100,000 shares for $3,290,500.00 (blended $32.90) on 2025-05-27 and 2025-05-28, representing a 0.9% reduction from his 10.62M pre-transaction holdings. The sales occurred near the 52-week range midpoint ($32.80 current price versus $28.17–$40.22 range), with the stock currently 18.4% below its 52-week high and up 11.9% over the trailing 30 days. His track record across all tickers shows a 90-day well-timed sell rate of 90.91% with an average 90-day return of -3.0% after sales, but his same-ticker history at CDRE remains inconclusive, with 3 recent prior sells in May 2025 having no measurable outcome yet and 2 March sells posting -0.8% and -3.6% 30-day returns. The company's fundamentals show $130.1M quarterly revenue with 17.6% annual growth and a P/E of 34.53, suggesting a high-growth profile at elevated valuation. The recurring sales pattern at CDRE within a compressed timeframe (five sales across May–March) merits observation against the company's growth trajectory and the insider's substantial remaining ownership stake of 10.52M shares.